Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Invokamet XR for the Treatment of Type 2 Diabetes in Adults

Drug

Invokamet XR (Canagliflozin / Metformin Hydrochloride Extended Release)

Product Description

Anti-hyperglycemic agent

Current Indication

Diabetes

Developer

Janssen Pharmaceuticals

Development Status

Approved in the US
Expand

Go Top